1. Home
  2. LWAY

as of 11-13-2026 3:28pm EST

$21.65
+$0.53
+2.51%
Stocks Consumer Staples Packaged Foods Nasdaq

Lifeway Foods Inc is engaged in manufacturing probiotic, cultured, functional dairy health food products. Its primary product is drinkable kefir, which is a cultured dairy product. Its product categories are Drinkable Kefir, which is the key revenue-driving product, European-style soft cheeses, Cream, ProBugs, Frozen Kefir, and Other dairy. The company manufactures and markets products under the Lifeway and Fresh Made brand names, as well as under private labels on behalf of customers. It sells the products through a direct sales force, brokers, and distributors.

Founded: 1986 Country:
United States
United States
Employees: N/A City: MORTON GROVE
Market Cap: 377.8M IPO Year: 1995
Target Price: $32.33 AVG Volume (30 days): 89.5K
Analyst Decision: Strong Buy Number of Analysts: 3
Dividend Yield:
N/A
Dividend Payout Frequency: quarterly
EPS: 0.33 EPS Growth: 48.33
52 Week Low/High: $17.31 - $32.71 Next Earning Date: 11-12-2026
Revenue: $103,350,000 Revenue Growth: N/A
Revenue Growth (this year): 22.8% Revenue Growth (next year): 11.41%
P/E Ratio: 68.13 Index:
Free Cash Flow: -16413000.0 FCF Growth: N/A

Stock Insider Trading Activity of Lifeway Foods Inc. (LWAY)

Sell
LWAY Nov 4, 2026

Avg Cost/Share

$22.95

Shares

70,000

Total Value

$1,583,360.86

Owned After

798,575

Sell
LWAY Oct 13, 2026

Avg Cost/Share

$22.64

Shares

30,000

Total Value

$679,200.00

Owned After

798,575

SEC Form 4

LWAY Oct 6, 2026

Avg Cost/Share

$20.80

Shares

50,000

Total Value

$1,040,190.00

Owned After

2,451,792

SEC Form 4

LWAY Oct 5, 2026

Avg Cost/Share

$21.01

Shares

36,202

Total Value

$760,535.24

Owned After

2,451,792

SEC Form 4

LWAY Oct 2, 2026

Avg Cost/Share

$21.09

Shares

17,482

Total Value

$368,669.16

Owned After

2,451,792

SEC Form 4

SMOLYANSKY JULIE

CEO, President and Secretary

Buy
LWAY Aug 19, 2026

Avg Cost/Share

$25.26

Shares

2,000

Total Value

$50,520.00

Owned After

2,214,095

SEC Form 4

LWAY Aug 17, 2026

Avg Cost/Share

$24.78

Shares

35,952

Total Value

$890,922.92

Owned After

2,451,792

SEC Form 4

Earnings Transcripts

SEC 8-K filings with transcript text

View All
2026
Q3

Q3 2026 Earnings

8-K SELL

Nov 12, 2026 · 100% conf.

AI Prediction SELL

1D

-2.61%

$20.57

Act: +2.75%

5D

-3.51%

$20.38

20D

+5.65%

$22.31

Price: $21.12 Prob +5D: 0% AUC: 1.000
0001683168-26-008612

EX-99.1

2 lifeway_ex9901.htm

PRESS RELEASE DATED NOVEMBR 12, 2026

Exhibit 99.1

Lifeway Foods® Reports Record High Quarterly Net Sales, Extends Kefir Category Leadership in Third Quarter 2026

28th consecutive quarter of year-over-year net sales growth; year-to-date 2026 net sales up 25.8%

Morton Grove, IL — November 12, 2026 — Lifeway Foods, Inc. (Nasdaq: LWAY) (“Lifeway” or “the Company”), the leading U.S. supplier of kefir and fermented probiotic foods, today announced financial results for the third quarter ended September 30, 2026.

“Lifeway delivered another record breaking quarter with net sales of $67.8 million, extending our streak of topline growth to 28 consecutive quarters,” said Julie Smolyansky, President and Chief Executive Officer of Lifeway Foods. “The consistent, volume-led growth we are seeing for our authentic Lifeway Kefir and Lifeway Farmer Cheese is extraordinary, reflecting the deep trust we have established with our growing consumer base and the ongoing commitment of our retailer partners. Our performance also reflects the rising demand for fermented dairy, as consumers increasingly seek functional, high quality-protein offerings and retailers identify ways to dedicate more shelf space to products like ours. With 7 years of uninterrupted growth and decades spent building this category, Lifeway is uniquely positioned to meet the moment and capitalize on this demand.”

Ms. Smolyansky continued, “Profitability this quarter continued to reflect an elevated input cost environment, and while we expect the cost pressure to persist in the fourth quarter, our outlook for 2027 has not changed. We expect the planned price increases  across our portfolio to take effect with distributors and retailers on a rolling basis through the end of the year and into the first quarter of 2027. With our pricing actions and the productivity gains we anticipate from our capacity investments, we expect gross margin expansion and improved profitability in 2027.   The scale-up of our Waukesha facility, scheduled for completion in early 2027, will eliminate capacity challenges we have encountered and allow us to serve the massive level of demand in front of us. We are well on pace to shatter our annual net sales record in 2026, and look forward to extending our category leadership and building on this momentum as we look ahead to 2027.”

Third Quarter 2026 Highlights

·Net Sales: $67.8 million, the highest quarterly net sales in Company history, up 18.6% year-over-year, primarily driven by higher volumes of the Company’s branded drinkable kefir.

·Gross Profit Margin: 18.0% , compared to 28.7% in the prior-year period, primarily reflecting elevated input costs including milk, resin-based packaging, ingredients, and transportation costs.

·Selling, general and administrative expenses were 16.2% of net sales, compared to 19.6% last year, reflecting continued investment in marketing and brand awareness.

·Net Income: $0.3 million, or $0.02 per basic and diluted common share, compared to net income of $3.5 million, or $0.23 per basic and diluted common share, in the prior-year period.

1

Year-to-Date 2026 Highlights

·Net Sales: $197.7 million, up 25.8% year-over-year.

·Gross Profit Margin: 21.5%, compared to 27.3% in the prior-year period.

·Selling, general and administrative expenses were 17.2% of net sales, compared to 19.1% last year,

·Net Income: $5.1 million, or $0.33 per basic and diluted common share, compared to net income of $11.3 million, or $0.75 per basic and $0.74 per diluted common share, in the prior-year period.

Historic Growth Record

·28 consecutive quarters of year-over-year net sales growth, reflecting seven years of uninterrupted quarterly growth.

·Four consecutive years of record annual net sales from 2022 through 2025, increasing from $141.6 million to $212.5 million – a cumulative increase of 50.1%.

·Year-to-date net sales equaled approximately 93% of full-year 2025 net sales, with the Company well on pace to set a record high in annual net sales in 2026, far exceeding the high-bar set in 2025.

Industry Recognition

In October, Lifeway was named to Fortune’s 2026 list of the 100 Fastest-Growing Companies, ranking No. 45, reflecting the Company’s sustained, volume-led growth and the strength of consumer demand for kefir and other cultured dairy products. This inclusion places Lifeway among an elite group of publicly traded companies that have delivered notably strong financial performance. This follows the induction of President and Chief Executive Officer Julie Smolyansky into the Specialty Food Association Hall of Fame this summer, in recognition of her leadership in transforming kefir from a niche product into a mainstream functional-food category.

Conference Call and Webcast

A live conference call and Q&A session with management discussing these results with additional comments and details will be made available through the “Investor Relations” section of the Company’s website

2026
Q2

Q2 2026 Earnings

8-K BUY

Aug 13, 2026 · 100% conf.

AI Prediction BUY

1D

+0.74%

$25.64

Act: +4.53%

5D

+3.68%

$26.39

20D

+7.12%

$27.27

Price: $25.45 Prob +5D: 100% AUC: 1.000
0001683168-26-006301

Transcript text not available. View on SEC.gov →

2026
Q1

Q1 2026 Earnings

8-K SELL

May 14, 2026 · 100% conf.

AI Prediction SELL

1D

-1.75%

$25.54

Act: -6.27%

5D

-3.52%

$25.08

Act: -3.42%

20D

+7.50%

$27.95

Act: -3.58%

Price: $26.00 Prob +5D: 0% AUC: 1.000
0001683168-26-003838

EX-99.1

2 lifeway_ex9901.htm

PRESS RELEASE DATED MAY 14, 2026.

Exhibit 99.1

Lifeway Foods® Announces Record-Breaking Results for the First Quarter Ended March 31, 2026

Achieves $63.0 million in net sales, a 37% volume-led net sales increase, driven by the Company’s flagship Lifeway Kefir

Record-breaking results signal robust Kefir &

Farmer Cheese growth, supported by the widening consumer focus on protein-rich, probiotic foods

Significant gross profit margin expansion of 360 basis points and net income growth of 32% reflect the Company’s disciplined operational execution

Morton Grove, IL — May 14, 2026 — Lifeway Foods, Inc. (Nasdaq: LWAY) (“Lifeway” or “the Company”), the leading U.S. supplier of kefir and fermented probiotic foods, today announced financial results for the first quarter ended March 31, 2026.

We kicked off 2026 with a blowout quarter that demonstrates the extraordinary momentum we’ve built across our business,” said Julie Smolyansky, President and Chief Executive Officer of Lifeway Foods. “We far exceeded our previous record with net sales of $63.0 million, up 37% year-over-year, surpassing sixty million in quarterly net sales for the first time and marking our 26th consecutive quarter of year-over-year growth. This exceptional top-line performance was accompanied by sizeable gross margin expansion of 360 basis points year-over-year, and equally strong net income growth of 32% that reflects a clean flow-through from our significant sales growth down to the bottom line. We are investing meaningfully behind our core products to support our rapid growth, and we continue to see impressive velocity acceleration. We also leveraged our SG&A by 300 basis points this quarter, demonstrating the increasing return and effectiveness of our investments.”

Ms. Smolyansky continued, “We believe Lifeway is uniquely positioned at the intersection of numerous consumer tailwinds with our on-trend, functional product offerings. The consumer focus on health and wellness continues to increase, gut-health awareness is spreading and demand from GLP-1 users seeking nutrient-dense, probiotic foods is particularly strong. We address each of these trends with our flagship Lifeway Kefir and high-protein Lifeway Farmer Cheese, while continuing to build a pipeline of innovative products, including Muscle Mates™ with creatine and probiotic Kefir Butter™. Together, these offerings bring new excitement to the category and expand our reach across the cultured dairy landscape. We are very excited about our trajectory and confident in our ability to execute throughout 2026 as we further capitalize on the growing consumer demand in our space.”

First Quarter 2026 Highlights

·Net Sales: $63.0 million, up 36.7% year-over-year.

·Gross Profit Margin: 27.5%, up 360 basis points from 23.9% last year.

·Selling, general and administrative expenses were $10.9 million, up 16.8% from last year, reflecting continued investment in marketing and brand awareness.

·Net Income: $4.7 million, or $0.31 per basic and $0.30 per diluted common share, compared to a net income of $3.5 million, or $0.23 per basic and diluted common share in the prior year.

Expanding Lifeway Visibility

Lifeway recently announced strategic partnerships, experiential marketing initiatives, and product innovation designed to elevate the brand’s visibility and engage health-conscious consumers nationwide.

·The Company partnered with Erewhon to launch the Tropical Lifeway Smoothie, made with Organic Lifeway Kefir, offering the ultimate summer refreshment reminiscent of a creamy frozen lemonade while delivering the added benefits of probiotics and protein.

·The Company hosted a retro-inspired Wellness House in Palm Springs during festival weekend, bringing together media, influencers, tastemakers and wellness enthusiasts for a celebration of Lifeway's legacy and continued role in shaping the modern wellness conversation.

·The Company celebrated forty years of Kefir leadership with new cultured dairy innovations at Expo West 2026, showcasing its Lifeway Muscle Mates™ and Lifeway Kefir Butter™.

1

Outlook

The Company reiterated its long-term target of

$45–$50 million in Adjusted EBITDA1 for FY 2027 and believes it is well positioned to deliver the strongest annual sales in Company history in FY 2026.

“Our momentum continues to build as we drive sustainable, profitable growth across the business,” Smolyansky concluded. “We have laid a foundation for durable, long-term value creation, and believe the investments we are making today in manufacturing capacity, marketing and innovation position us exceptionally well to capitalize on the tremendous opportunities ahead.”

1.Adjusted EBITDA is a non-GAAP financial measure. Adjusted EBITDA is defined as Operating Income, as reported, plus Depreciation and Amortization, plus Stock-Based Compensation.

Conference Call and Webcast

A webcast with Lifeway’s President and Chief Executive Officer discussing these results wit

Share on Social Networks: